Astellas Names Michael Petroutsas as Head of US Commercial [Yahoo! Finance]
ASTELLAS PHARMA UNSP/ADR (ALPMY)
NASDAQ:AMEX Investor Relations:
astellas.com/jp/en/investors
Company Research
Source: Yahoo! Finance
Head, United States Commercial, leading the Astellas Pharma US Inc. organization. Petroutsas will be responsible for the company's US commercial operations. Petroutsas will succeed Mark Reisenauer , who is leaving Astellas at the end of March. "With more than 25 years of experience in the pharmaceutical industry, Mike has effectively led extensive global commercial, strategic, and operational teams. Mike exemplifies leadership through his consistent delivery of high performance. I am assured that his commitment and dedication will empower Astellas in the US, our biggest market globally, to provide the utmost value for patients," said Claus Zieler , Chief Commercial Officer. "I am inspired by Astellas' mission and strong reputation to deliver ground-breaking, innovative medicines that can transform the lives of patients with the highest need," said Petroutsas. "I'm committed to putting patients first to create healthcare solutions that matter and excited to begin this next chapte
Show less
Read more
Impact Snapshot
Event Time:
ALPMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALPMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALPMY alerts
High impacting ASTELLAS PHARMA UNSP/ADR news events
Weekly update
A roundup of the hottest topics
ALPMY
News
- Bayer Menopause Drug Shows Positive Result in Late-Stage Trials [BNN Bloomberg (Canada)]BNN Bloomberg
- Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor [Yahoo! Finance]Yahoo! Finance
- Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech CorridorPR Newswire
- Announcing More Customer Expansions [Yahoo! Finance]Yahoo! Finance